NEO Bio Lab Global Headquarters

3-D Matrix is a global leader in peptide solutions, dedicated to developing innovative healthcare treatments that enhance patient outcomes through self-assembling peptide technology. Founded as a spinoff from MIT in 2004 and headquartered in Tokyo, Japan, the company collaborates with healthcare professionals worldwide to ensure their products meet clinical needs effectively. With a strong presence in America, Europe, and Asia, 3-D Matrix maintains a robust network of partners and distributors committed to delivering high-quality support and medical solutions. Their offerings, including PuraStat and PuraBond, are backed by extensive clinical and laboratory testing, demonstrating their focus on data-driven healthcare solutions. Generated from the website

Aura Biosciences, based in Cambridge, MA, is pioneering a novel targeted oncology platform aimed at establishing a new standard of care for various cancer types, with an initial emphasis on ocular and urologic oncology. Utilizing their proprietary Virus-Like Drug Conjugates (VDCs), the company targets a wide range of solid tumors, including the rare and life-threatening choroidal melanoma, for which current treatment options are limited and often result in significant vision loss. With a commitment to innovation, Aura Biosciences addresses the urgent need for effective therapies that can improve patient outcomes, particularly in cases where existing treatments have proven inadequate. The company's mission is driven by a passion to help cancer patients through the development of advanced therapeutic solutions. Generated from the website